Immune Treatment Strategies in Unexplained Recurrent Pregnancy Loss
American Journal of Reproductive Immunology · 2025
DOI: 10.1111/aji.70060 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Rui Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Reproductive Medical Center, Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Abortion, Habitual, Immunotherapy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 123 Literaturangaben. Gefördert von: Sichuan Province Science and Technology Department.
Abstract (Originalsprache)
Recurrent pregnancy loss (RPL) is characterized by the occurrence of two or more consecutive pregnancy losses. Approximately half of these cases lack a clear etiology and are termed unexplained recurrent pregnancy loss (URPL). Maternal–fetal immune dysfunction is thought to be involved in causing URPL. Increased human leukocyte antigen compatibility, susceptibility genes, lack of blocking antibodies, and dysfunction of immune cells can all disrupt the immune tolerance environment of the maternal–fetal interface. To correct the maternal–fetal immune imbalances, some immunotherapies were recently tried to be used for patients with URPL. This review summarizes the characteristics and mechanisms of the immune microenvironment at the maternal–fetal interface of URPL patients, and the present immunotherapies for URPL patients, to serve as a reference for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Reproductive Medical Center, Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial T…
- Department of Outpatient, West China Second University Hospital, Sichuan University, Chengdu, China.
- Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Förderung
- Sichuan Province Science and Technology Department
Zitieren
APA
Cai, R., Yang, Q., Liao, Y., Qin, L., Han, J., & Gao, R. (2025). Immune Treatment Strategies in Unexplained Recurrent Pregnancy Loss. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70060
Vancouver
Cai R, Yang Q, Liao Y, Qin L, Han J, Gao R. Immune Treatment Strategies in Unexplained Recurrent Pregnancy Loss. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70060
BibTeX
@article{Cai2025,
author = {Cai, Rui and Yang, Qiaoran and Liao, Yingjun and Qin, Lang and Han, Jinbiao and Gao, Rui},
title = {Immune Treatment Strategies in Unexplained Recurrent Pregnancy Loss},
journal = {American Journal of Reproductive Immunology},
year = {2025},
doi = {10.1111/aji.70060}
}
EUVIMED